HEMAVANT

Trademark usage description

pharmaceutical preparations for human use for the treatment and prevention of hematological, bleeding and bone marrow conditions, disorders and diseas Read More

Classification Information

Class [005]
Pharmaceutical preparations for human use for the treatment and prevention of hematological, bleeding and bone marrow conditions, disorders and diseases, including those that relate to immunologic, hemostatic (blood clotting) and vascular systems; biologic preparations for medical and therapeutic purposes for the treatment of hematological and bleeding conditions, disorders and diseases

Classification kind code

Class [042]
Scientific and technological services and research and design relating thereto, namely medical research, scientific research and analysis in the fields of biomedicine, pharmaceutical, biological therapeutic preparations, clinical trials and post-market trials; pharmaceutical, biomedical and biological therapeutic research services; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials.

Classification kind code

Class [044]
Providing health and medical information in the fields of hematology, bleeding, bone marrow, immunologic, hemostatic (blood clotting) and vascular system diseases, and disorders, pharmaceuticals and biomedicine; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; diagnostic services in the field of hematology, bleeding, bone marrow, immunologic, hemostatic (blood clotting) and vascular system diseases and disorders

Classification kind code

Mark Details

Serial Number

1912826

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 11^th Aug 2021	Advertised
Submitted for opposition 26 on 14^th Jul 2021	Approved
Submitted for opposition 27 on 14^th Jul 2021	Approval Notice Sent
Submitted for opposition 15 on 24^th Dec 2020	Correspondence Created
Submitted for opposition 15 on 18^th Sept 2020	Correspondence Created
Submitted for opposition 20 on 13^th Jan 2020	Examiner's First Report
Submitted for opposition 22 on 19^th Dec 2019	Search Recorded
Submitted for opposition 31 on 3^rd Aug 2018	Formalized
Submitted for opposition 1 on 2^th Aug 2018	Created
Submitted for opposition 30 on 1^st Aug 2018	Filed